The interplay between mutant p53 and the mevalonate pathway.

about

New therapeutic strategies to treat human cancers expressing mutant p53 proteins.Complexes formed by mutant p53 and their roles in breast cancer.Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.

P2860

Q49962911-E69C1ADF-7396-4194-ABF7-8CD9302DA396 Q55333537-6911A3D7-F512-4F57-B54F-5D0B550F8472 Q55515721-53EAE1BC-8BF8-4FFE-82D1-9F2F19252CC4

P2860

The interplay between mutant p53 and the mevalonate pathway.

Item

http://www.wikidata.org/entity/Q47296038

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The interplay between mutant p53 and the mevalonate pathway.

@en

The interplay between mutant p53 and the mevalonate pathway.

@nl

type

Item

label

The interplay between mutant p53 and the mevalonate pathway.

@en

The interplay between mutant p53 and the mevalonate pathway.

@nl

prefLabel

The interplay between mutant p53 and the mevalonate pathway.

@en

The interplay between mutant p53 and the mevalonate pathway.

@nl

P1476

The interplay between mutant p53 and the mevalonate pathway.

@en

P2093

Alejandro Parrales

http://www.w3.org/2001/XMLSchema#string

Elizabeth Thoenen

http://www.w3.org/2001/XMLSchema#string

Tomoo Iwakuma

http://www.w3.org/2001/XMLSchema#string

P2860

Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway

Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53.

GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo

Oncogenic Intra-p53 Family Member Interactions in Human Cancers

Targeting Oncogenic Mutant p53 for Cancer Therapy

Current and Emerging Uses of Statins in Clinical Therapeutics: A Review

Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization

Phosphorylation and hsp90 binding mediate heat shock stabilization of p53

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility

P2888

s41418-017-0026-y

P31

scholarly article

review article

P356

10.1038/S41418-017-0026-Y

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1099657776

http://www.w3.org/2001/XMLSchema#string

P698

29238070

http://www.w3.org/2001/XMLSchema#string

P932

5864191

http://www.w3.org/2001/XMLSchema#string

The interplay between mutant p53 and the mevalonate pathway.

about

P2860

P2860

The interplay between mutant p53 and the mevalonate pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P932